<SEC-DOCUMENT>0001628280-24-040456.txt : 20240916
<SEC-HEADER>0001628280-24-040456.hdr.sgml : 20240916
<ACCEPTANCE-DATETIME>20240916152420
ACCESSION NUMBER:		0001628280-24-040456
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240819
FILED AS OF DATE:		20240916
DATE AS OF CHANGE:		20240916

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Antunes Humberto Calheiros
		CENTRAL INDEX KEY:			0001800145
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27446
		FILM NUMBER:		241300882

	MAIL ADDRESS:	
		STREET 1:		C/O AVADIM HEALTH, INC.
		STREET 2:		81 THOMPSON STREET
		CITY:			ASHEVILLE
		STATE:			NC
		ZIP:			28803

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIFECORE BIOMEDICAL, INC. \DE\
		CENTRAL INDEX KEY:			0001005286
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				943025618
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0526

	BUSINESS ADDRESS:	
		STREET 1:		3515 LYMAN BOULEVARD
		CITY:			CHASKA
		STATE:			MN
		ZIP:			55318
		BUSINESS PHONE:		9523684300

	MAIL ADDRESS:	
		STREET 1:		3515 LYMAN BOULEVARD
		CITY:			CHASKA
		STATE:			MN
		ZIP:			55318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LANDEC CORP \CA\
		DATE OF NAME CHANGE:	19951222
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>wk-form4a_1726514653.xml
<DESCRIPTION>FORM 4/A
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2024-08-19</periodOfReport>

    <dateOfOriginalSubmission>2024-08-21</dateOfOriginalSubmission>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001005286</issuerCik>
        <issuerName>LIFECORE BIOMEDICAL, INC. \DE\</issuerName>
        <issuerTradingSymbol>LFCR</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001800145</rptOwnerCik>
            <rptOwnerName>Antunes Humberto Calheiros</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O LIFECORE BIOMEDICAL, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>3515 LYMAN BLVD.</rptOwnerStreet2>
            <rptOwnerCity>CHASKA</rptOwnerCity>
            <rptOwnerState>MN</rptOwnerState>
            <rptOwnerZipCode>55318</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2024-08-19</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>24554</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>27554</value>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes>
        <footnote id="F1">The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.</footnote>
        <footnote id="F2">Vests on earlier of July 8, 2025 or the date of the annual meeting of stockholders of the Company first held in calendar year 2025 (provided such date is no less than 50 weeks from July 8, 2024).</footnote>
        <footnote id="F3">Amendment includes 3,000 shares that were inadvertently omitted from the Form 3 filed on behalf of the reporting person on August 21, 2024.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Rebecca J Hilt Attorney-In-Fact for Humberto C. Antunes</signatureName>
        <signatureDate>2024-09-16</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
